Suppr超能文献

联合急性左旋多巴激发试验和嗅觉测试对预测帕金森病的诊断价值

Diagnostic Value of Combined Acute Levodopa Challenge and Olfactory Testing to Predict Parkinson's Disease.

作者信息

Terroba Chambi Cinthia, Rossi Malco, Bril Andrea, Vernetti Patricio Millar, Cerquetti Daniel, Cammarota Angel, Merello Marcelo

机构信息

Movement Disorders Section Neuroscience Department Raul Carrea Institute for Neurological Research (FLENI) Buenos Aires Argentina.

Argentine National Scientific and Technological Research Council (CONICET) Buenos Aires Argentina.

出版信息

Mov Disord Clin Pract. 2017 Sep 3;4(6):824-828. doi: 10.1002/mdc3.12517. eCollection 2017 Nov-Dec.

Abstract

BACKGROUND

The diagnosis of Parkinson's disease (PD) can be challenging early in the disease course, when motor features are subtle. The objective of this study was to explore the diagnostic value of combining acute levodopa challenge and olfactory testing to predict PD.

METHODS

Data from 210 patients with a recent onset of parkinsonism who had at least 2 years of follow-up and underwent acute levodopa challenge for the clinical prediction of long-term dopaminergic response and had olfactory testing with Sniffin' Sticks Test were evaluated. Single and combined diagnostic measures were analyzed.

RESULTS

After 2 years of follow-up, a PD diagnosis was confirmed in 157 patients who fulfilled United Kingdom Parkinson's Disease Society Brain Bank criteria and was ruled out in 53. Sensitivity and specificity of acute levodopa challenge to predict PD diagnosis were 0.71 and 0.94, respectively. Sensitivity and specificity of olfactory tests were calculated according to the total olfactory score for hyposmia (0.61 and 0.77 respectively), the hyposmia identification subscore (0.63 and 0.74, respectively), and the anosmia score (0.40 and 0.85, respectively). The best combination identified was response to acute levodopa challenge together with hyposmia according to the total olfactory score (sensitivity, 0.90; specificity, 0.74; positive predictive value, 0.91; negative predictive value, 0.72; accuracy, 0.86).

CONCLUSION

The combination of response to acute levodopa challenge with hyposmia according to the total olfactory score improved sensitivity for the early diagnosis of PD.

摘要

背景

帕金森病(PD)在疾病早期,当运动特征不明显时,其诊断具有挑战性。本研究的目的是探讨联合急性左旋多巴激发试验和嗅觉测试对帕金森病的诊断价值。

方法

对210例近期发病的帕金森综合征患者的数据进行评估,这些患者至少随访2年,接受了急性左旋多巴激发试验以预测长期多巴胺能反应,并进行了嗅觉棒测试。分析了单一和联合诊断措施。

结果

随访2年后,157例符合英国帕金森病协会脑库标准的患者被确诊为帕金森病,53例被排除。急性左旋多巴激发试验预测帕金森病诊断的敏感性和特异性分别为0.71和0.94。嗅觉测试的敏感性和特异性根据嗅觉减退的总嗅觉评分(分别为0.61和0.77)、嗅觉减退识别子评分(分别为0.63和0.74)和嗅觉丧失评分(分别为0.40和0.85)计算。确定的最佳组合是急性左旋多巴激发试验反应与根据总嗅觉评分判断的嗅觉减退(敏感性0.90;特异性0.74;阳性预测值0.91;阴性预测值0.72;准确性0.86)。

结论

急性左旋多巴激发试验反应与根据总嗅觉评分判断的嗅觉减退相结合,提高了帕金森病早期诊断的敏感性。

相似文献

1
Diagnostic Value of Combined Acute Levodopa Challenge and Olfactory Testing to Predict Parkinson's Disease.
Mov Disord Clin Pract. 2017 Sep 3;4(6):824-828. doi: 10.1002/mdc3.12517. eCollection 2017 Nov-Dec.
2
Olfactory Dysfunction and Its Relationship With Clinical Features of Parkinson's Disease.
Front Neurol. 2020 Oct 16;11:526615. doi: 10.3389/fneur.2020.526615. eCollection 2020.
4
Acute challenge with apomorphine and levodopa in Parkinsonism.
Eur Neurol. 2000;43(2):95-101. doi: 10.1159/000008142.
5
Olfactory Dysfunction Predicts Disease Progression in Parkinson's Disease: A Longitudinal Study.
Front Neurosci. 2020 Dec 14;14:569777. doi: 10.3389/fnins.2020.569777. eCollection 2020.
6
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1939-1950. doi: 10.1007/s00259-021-05666-9. Epub 2022 Jan 5.
7
Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):441-7. doi: 10.1136/jnnp-2011-301719. Epub 2012 Feb 22.
8
Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.
Parkinsonism Relat Disord. 2017 Feb;35:36-41. doi: 10.1016/j.parkreldis.2016.11.010. Epub 2016 Nov 21.
9
Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.
Parkinsonism Relat Disord. 2012 May;18(4):358-61. doi: 10.1016/j.parkreldis.2011.12.001. Epub 2012 Jan 5.
10
Motor features in Parkinson's disease with normal olfactory function.
Mov Disord. 2016 Sep;31(9):1414-7. doi: 10.1002/mds.26687. Epub 2016 Jun 9.

引用本文的文献

2
Definition and diagnosis of Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.
J Neurol. 2024 Nov;271(11):7102-7119. doi: 10.1007/s00415-024-12687-5. Epub 2024 Sep 19.
3
Instrumented timed up and go test and machine learning-based levodopa response evaluation: a pilot study.
J Neuroeng Rehabil. 2024 Sep 18;21(1):163. doi: 10.1186/s12984-024-01452-4.
4
Olfactory functional covariance connectivity in Parkinson's disease: Evidence from a Chinese population.
Front Aging Neurosci. 2023 Jan 4;14:1071520. doi: 10.3389/fnagi.2022.1071520. eCollection 2022.
5
International consensus statement on allergy and rhinology: Olfaction.
Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929.
6
Olfactory dysfunction in aging and neurodegenerative diseases.
Ageing Res Rev. 2021 Sep;70:101416. doi: 10.1016/j.arr.2021.101416. Epub 2021 Jul 27.
7
Levodopa challenge test: indications, protocol, and guide.
J Neurol. 2021 Sep;268(9):3135-3143. doi: 10.1007/s00415-020-09810-7. Epub 2020 Apr 24.
8
The neuroplastic effect of olfactory training to the recovery of olfactory system in mouse model.
Int Forum Allergy Rhinol. 2019 Jul;9(7):715-723. doi: 10.1002/alr.22320. Epub 2019 Feb 21.

本文引用的文献

1
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.
Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017.
2
Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.
Parkinsonism Relat Disord. 2017 Feb;35:36-41. doi: 10.1016/j.parkreldis.2016.11.010. Epub 2016 Nov 21.
3
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.
Mov Disord. 2016 Sep;31(9):1408-13. doi: 10.1002/mds.26637. Epub 2016 May 9.
4
Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.
Neurology. 2016 Feb 9;86(6):566-76. doi: 10.1212/WNL.0000000000002350. Epub 2016 Jan 13.
5
Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.
Chem Senses. 2016 Jan;41(1):77-83. doi: 10.1093/chemse/bjv062. Epub 2015 Oct 28.
6
MDS clinical diagnostic criteria for Parkinson's disease.
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
7
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Lancet Neurol. 2015 Oct;14(10):1002-9. doi: 10.1016/S1474-4422(15)00178-7. Epub 2015 Aug 10.
8
A population-based study on combined markers for early Parkinson's disease.
Mov Disord. 2015 Apr;30(4):531-7. doi: 10.1002/mds.26100. Epub 2014 Dec 27.
9
Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders.
Int J Clin Pract. 2014 Nov;68(11):1345-51. doi: 10.1111/ijcp.12445. Epub 2014 Apr 22.
10
Criteria for the diagnosis of corticobasal degeneration.
Neurology. 2013 Jan 29;80(5):496-503. doi: 10.1212/WNL.0b013e31827f0fd1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验